Immunology Flashcards

(57 cards)

1
Q

Splenic dysfunction impact

A

increased encapsulated organism risk

decreased IgM causes less C3b opsonization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Positive selection of T lymphocytes

A

in cortex of thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Negative selection of T cells

A

medulla of thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recombination of pathogen receptors genes

A

VDJ in lymphocyte development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MHC I characteristics

A

HLA-A,B,C
all nucleated cells
pairs with beta-microglobulin
loaded in RER with intracellular peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MCH II characteristics

A

only on APCs
HLA-DR,DP,DQ
loaded following release of invariant chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HLA B27 assc

A

psoriasis
ankylosing spondylitits
IBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HLA DR2 assc

A

MS
SLE
Goodpasture’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Activation of naive T cells

A

B7 and CD28 interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

B cell activation for class switching

A

CD40 receptor on B cells bound by CD40L of T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Regulatory T cell markers

A

CD3
CD4
CD25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complement binding site on Abs

A

Fc region

determines isotype of Ig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ab diversity gene

A

V(D)J heavy chain genes
VJ light chain genes
done by somatic hypermutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Activation of complement

A

IgG and IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Opsonization in complement system

A

C3b and IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neutrophil chemotaxis in complement system

A

C5a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MAC cell lysis in complement

A

C5b-C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Result of C5-C9 deficiency

A

Recurrent Neisseria infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ig differentiation cytokines

A

IL-4 does IgE and IgG production

IL-5 does IgA production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Role of interferon alpha and beta

A

inhibits viral protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Role of intefereon gamma

A

increase MHC I and II expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

B cell surface markers

A

CD19
CD20
CD21 (for EBV receptor)
CD40 (for acivation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Bugs with antigenic variation (5)

A
Salmonella
Borrelia
N. gonorrheae (maltose (-))
influenza
trypanosomes
24
Q

Impact of live attenuated vaccine

A

cellular response

life-long immunity

25
Impact of killed vaccine
humoral immunity by surface antigen response | needs booster shot
26
Type II hypersensitivity rxn diseases
Pernicious anemia Rheumatic fever Goodpasture's syndrome
27
Type IV hypersensitivity rxn diseases
MS Guillian-Barre syndrome PPD test
28
Type III hypersensitivity rxn diseases
SLE | poststrep glomerulonephritis
29
HS type of blood transfusion acute hemolytic or febrile nonhemolytic transfusion rxns
type II HS
30
Anti-dsDNA/anti-Smith disease
SLE
31
Anti-Scl-70 disease/anti-centromere
scleroderma
32
Anti-basement membrane disease
Goodpasture's
33
Anti-SSA/SSB disease
Sjogren's syndrome
34
c-ANCA disease
Wegener's granulomatosis
35
p-ANCA disease
Churg-Strauss/microscopic polyangiitis
36
Tyrosine kinase gene defect | recurrent bacterial infections after 6 months
``` X linked (bruton's) apammaglobulinemia defect in BTK no B cell maturation opsonization defect ```
37
Hypocalcemia recurrent viral/fungal infections no T cells
Digeorge's syndrome no thymus 22q11 deletion 3rd and 4th pharyngeal pouches
38
Failure to thrive recurrent infections of all types low T cells
SCID | defective IL-2 receptor (X-linked) or adenosine deaminase defect
39
Cerebellar defects IgA deficiency spider angiomas
Ataxia-telangiectasia ATM gene defect DNA repair enzymes
40
Increased IgM | severe pyogenic infection in infancy
``` Hyper IgM syndrome defect in CD40L on T helper cells no class switching ```
41
Thrombocytopenic purpura infections eczema X-linked
Wiskott Aldrich syndrome WAS gene T cells cannot reogranize actin
42
Recurrent infections | no pus formation
Leukocyte adhesion deficiency | defect in LFA-1 integrin (CD18)
43
Partial albinism recurrent pyogenic infections (staph/strep) giant neutrophil granules
Chediak-Higashi syndrome AR defect in LYST microtubule dysfunction of lysosome fusion
44
Increased S aureus/E. coli/aspergillus infections
Chronic granulomatous disease lack of NADPH oxidase no respiratory burst in neutrophils
45
Hyperacute transplant rejection
within minutes Type II HS preformed anti-donor Abs ischemia/necrosis
46
Acute transplant rejection
within weeks cell mediated to CTL against foreign MHC's immunosuppressants work
47
Chronic transplant rejection
month-yrs class MHC-1 on donor detected as nonself, T cells destroy donor cells irreversible/fibrosis
48
Graft vs Host disease
immunocompetent cells donated attack host organs maculopapular rash hepatosplenomegaly diarrhea
49
MOA of cyclosporine
blocks T cell activation by calcineurin inhibition
50
MOA of tracolimus
binds FK-binding protein | inhibits calcineurin and IL-2 secretion
51
MOA of sirolimus
inhibits mTOR | no T cell proliferation via IL-2
52
MOA azathioprine
6-MCP precursor | nucleic acid syntehsis inhibitor
53
IgA Antiendomysial
Celiac disease
54
Antimitochondrial Abs
Primary biliary cirrhosis
55
Antimicrosomal Abs
Hashimoto's thyroiditis
56
Antismooth muscle Abs
autoimmune hepatitis
57
Anti-glutamate decarboxylase
type I DM